| Collaborative research in modern era: Need and challenges S Bansal, S Mahendiratta, S Kumar, P Sarma, A Prakash, B Medhi Indian journal of pharmacology 51 (3), 137-139, 2019 | 86 | 2019 |
| Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a … S Kumar, P Sarma, H Kaur, M Prajapat, A Bhattacharyya, P Avti, ... Tissue and Cell 70, 101497, 2021 | 45 | 2021 |
| Futuristic approach to cancer treatment D Malik, S Mahendiratta, H Kaur, B Medhi Gene 805, 145906, 2021 | 29 | 2021 |
| Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review S Mahendiratta, S Bansal, P Sarma, H Kumar, G Choudhary, S Kumar, ... Biomedicine & pharmacotherapy 137, 111300, 2021 | 29 | 2021 |
| Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review S Mahendiratta, G Batra, P Sarma, H Kumar, S Bansal, S Kumar, ... Life sciences 258, 118207, 2020 | 27 | 2020 |
| Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy P Sarma, S Mahendiratta, A Prakash, B Medhi Indian Journal of Pharmacology 50 (1), 1-3, 2018 | 20 | 2018 |
| Premature graying of hair: Risk factors, co‐morbid conditions, pharmacotherapy and reversal—A systematic review and meta‐analysis S Mahendiratta, P Sarma, H Kaur, S Kaur, H Kaur, S Bansal, D Prasad, ... Dermatologic Therapy 33 (6), e13990, 2020 | 17 | 2020 |
| A preliminary study to evaluate the behavior of Indian population toward E-pharmacy S Bansal, H Kaur, S Mahendiratta, P Sarma, S Kumar, AR Sharma, ... Indian Journal of Pharmacology 54 (2), 131-137, 2022 | 10 | 2022 |
| Therapeutic options for management of Hori's nevus: A systematic review H Kaur, P Sarma, S Kaur, H Kaur, M Prajapat, S Mahendiratta, S Kumar, ... Dermatologic therapy 33 (1), e13167, 2020 | 9 | 2020 |
| Everolimus: A potential therapeutic agent targeting PI3K/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficits S Bansal, M Agrawal, S Mahendiratta, S Kumar, S Arora, R Joshi, ... Fundamental & Clinical Pharmacology 35 (6), 1018-1031, 2021 | 4 | 2021 |
| Role of protein tyrosine phosphatase 1B inhibitor in central insulin resistance and associated cognitive deficits S Bansal, S Mahendiratta, M Agrawal, S Kumar, AR Sharma, N Garg, ... Brain Research Bulletin 171, 113-125, 2021 | 4 | 2021 |
| In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy M Prajapat, P Sarma, N Shekhar, H Kaur, S Singh, S Kumar, H Kaur, ... Journal of Advanced Pharmaceutical Technology & Research 11 (4), 194-201, 2020 | 3 | 2020 |
| Social Pharmacology and its impact on clinics S Bansal, S Mahendiratta, A Prakash, B Medhi Indian Journal of Pharmacology 53 (6), 437-439, 2021 | 2 | 2021 |
| Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation S Kumar, H Singh, M Prajapat, P Sarma, A Bhattacharyya, H Kaur, G Kaur, ... Bioinformatics and Biology Insights 17, 11779322231171777, 2023 | 1 | 2023 |
| Overview of Affordable Upfront Point-of-Care Testing for Cancer Detection S Kumar, SK Pandey, P Sarma, A Bhattacharyya, H Kaur, M Prajapat, ... Nanobiosensors for point-of-care medical diagnostics, 137-154, 2023 | 1 | 2023 |
| Current practices in oncology drug delivery S Mahendiratta, S Bansal, S Kumar, P Sarma, A Prakash, B Medhi Advanced Drug Delivery Systems in the Management of Cancer, 17-26, 2021 | 1 | 2021 |
| Integrated in-silico and in-vitro assessments of HDAC6 inhibitor efficacy in mitigating amyloid beta pathology in Alzheimer’s disease G Choudhary, M Prajapat, G Kaur, H Singh, S Mahendiratta, A Prakash, ... Journal of Biomolecular Structure and Dynamics, 1-11, 2023 | | 2023 |
| Nanoparticles in Chronic Respiratory Diseases A Raja, S Mahendiratta, H Singh, N Shekhar, A Prakash, B Medhi Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung …, 2022 | | 2022 |
| Pattern of pharmacological research from the last six decades R Joshi, S Mahendiratta, A Prakash, B Medhi Indian Journal of Pharmacology 51 (2), 85-87, 2019 | | 2019 |
| Vaccines for COVID-19 PK Saifuddin, A Bhattacharyya, P Sarma, S Mahendiratta, H Kaur, ... | | |
